Skip to main content
. 2021 Dec 11;21:411. doi: 10.1186/s12890-021-01783-1

Table 2.

Diseases included in non-IPF studies

Studies Year published Medication Diseases Included
Flaherty et al. INBUILD trial 2019 Nintedanib iNSIP1, uIIP2, HP3, RA-ILD4, MCTD-ILD5, SSc-ILD6 and others
Distler et al. NCT 02597933 2019 Nintedanib SSc-ILD6
Maher et al. 2020 Pirfenidone Unclassifiable ILD
Behr et al. 2021 Pirfenidone iNSIP1, HP3, RA-ILD4, MCTD-ILD5, SSc-ILD6, asbestos-related fibrosis